What I Didn't Expect When I Started Building This Course

A candid update from Dr. Douglas Meyer — Meyer Chiropractic & Acupuncture

My thoughts on Alpha-Gal Syndrome as I prepare to teach my first CE class, June 13, 2026 at Logan University

A Condition That Refuses to Stay Still

Part of what makes Alpha-Gal Syndrome so clinically compelling — and so challenging to teach — is that it refuses to be contained in a single specialty box. I started pulling from allergy, immunology, rheumatology, cardiology, gastroenterology, neurology, and integrative medicine — and the threads just kept connecting. The mast cell piece alone opened up an entirely different dimension of how we understand fascial pain, joint inflammation, and central sensitization in our patients.

What began as a course on "this tick-borne allergy you should know about" has become something I think is genuinely important for chiropractors and acupuncturists to understand — not just as a diagnostic consideration, but as a lens that changes how you look at a significant portion of your chronic pain population.

The geographic spread of the Lone Star tick alone should get every practitioner's attention. AGS is no longer a Southern U.S. problem. Cases are appearing across the Northeast and Midwest at rates that would have seemed impossible ten years ago. These patients are in our waiting rooms — many of them have been for years — carrying a diagnosis of fibromyalgia, or post-Lyme syndrome, or "unexplained chronic pain," when the actual root driver has never been identified.

What the Course Covers

The eight-hour CEU at Logan University on June 13th is designed to give practitioners the full clinical picture — from the basic science of mast cell activation and IgE-mediated response, to the musculoskeletal, fascial, and neurological mechanisms that make AGS relevant to daily practice. We cover how to screen patients, what to look for in intake, how the delayed reaction pattern causes the condition to be chronically misidentified, and how both chiropractic and acupuncture interventions map onto the biological mechanisms involved.

I am particularly proud of the sections on the vagal anti-inflammatory pathway and how spinal manipulation and electroacupuncture both activate it — directly suppressing the same cytokines that drive AGS-mediated joint and myofascial pain. That mechanistic bridge between what we do clinically and what the research supports is something I hope practitioners leave the course with a deeper appreciation for.

The truth is, this course is still evolving. That is both the challenge and the excitement of teaching something this timely.

What I Want Our Patients and Community to Know

If you or someone you love has been diagnosed with Alpha-Gal Syndrome — or suspects they might have it — I want you to know something simple and important: there are options.

AGS is real. It is affecting far more people than we originally thought, presenting with a vast and often confusing array of symptoms — chronic joint pain, fatigue, GI distress, skin reactions, brain fog, and more. Correcting the whole-body physiology that AGS disrupts — particularly the chronic inflammation at its core — requires a comprehensive, sustained approach.

Those who came in already managing underlying health conditions tend to be the most significantly affected. When your body is already under a chronic burden and AGS enters the picture, the compounding effect can be profound. These are often the patients who have been most dismissed and most in need of a practitioner who understands the full picture.

Chiropractic and acupuncture are not workarounds for AGS. They are direct clinical interventions in the mechanisms driving it — the mast cell activation, the fascial inflammation, the nervous system dysregulation, the immune burden. We work with the body's own systems to reduce that load and restore function.

If you have questions, if you have been struggling to find answers, or if you simply want to understand whether what you are experiencing could be connected to Alpha-Gal Syndrome — reach out.

I want to be honest with you. I don't have all the answers when it comes to Alpha-Gal Syndrome — and I'm not sure anyone does yet. The research is ever-changing, and this condition continues to surprise even the most experienced clinicians. What I do know with certainty is that it is real, and it is quietly changing the lives of a significant number of people in our community — affecting how they feel, how they function, and how they interact with the world around them.

What I also know is that my protocol has been helping people. Patients are experiencing measurable reductions in symptoms, and we are seeing meaningful changes when we test their levels over time. That matters to me. And it keeps me digging.

Yours in health,

Dr. Douglas Meyer